SELL and neoplasm: Tumor infiltrating T lymphocytes (TIL) have been shown to be more efficient in ACT, but mostly display an activated and further differentiated phenotype (CD45RO+, MHC class II+) [25] and the majority of these cells are CD45RA−/CD62L− (Figure 5A).